Popular Articles

Jul 01, 2011
Pharmaceutical Executive
'Like' and 'Dislike' practices in the virtual Facebook pharmaceutical world.
Jul 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
EAB Member Al Topin delivers 10 questions that should drive your brand-building marketing program.
Jul 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
What India's latest census tells us about current and future pharma opportunities.
May 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A factory tour to examine Merck's automated robots—and the human minds that inspire them
May 01, 2011
Pharmaceutical Executive
Stiff price tags draw scrutiny from Congress and consumers, and raise questions about FDA policies
May 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Who's taken this year's top spot? Find out in Pharm Exec's annual run-down of the world's Top 50 pharma companies.
May 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Why is building a successful marketing program so difficult? It should be simple, if your product is worth marketing.
May 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance
Mar 01, 2011
Pharmaceutical Executive
Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.
Mar 01, 2011
Pharmaceutical Executive
Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision
native1_300x100
lorem ipsum